0 CHECKOUT

Summary: Lafayette Public Trust Financing Authority, Louisiana Ragin' Cajun Facilities Corp.; Auxiliary - System; Public Coll/Univ - Unlimited Student Fees Mar 12

  • ID: 2084563
  • March 2012
  • Region: Louisiana
  • Standard & Poors
1 of 3

Abstract
Standard & Poor's Ratings Services affirmed its 'A' long-term rating on the Lafayette Public Trust Financing Authority, La.'s series 2010 higher education revenue bonds (student union bonds), issued on behalf of Ragin' Cajun Facilities Corp. at the University of Louisiana-Lafayette, La. (UL-L). Standard and Poor's also affirmed its 'BBB+' underlying rating (SPUR) on the corporation's outstanding series 2010 and 2009 housing and parking bonds (auxiliary facility revenue bonds). The outlook on all ratings is stable. In our view, ULL's stable enrollment and strong coverage of both the student union and auxiliary debt support the rating. This offsets, in our opinion, its recent history of negative full-accrual operating performance due to noncash expense accruals of other post-employment benefits (OPEB), which also...

Companies mentioned in this report are: Ragin' Cajun Facs Corp ,Lafayette Pub Trust Fincg Auth
Action: Affirmed

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Ragin' Cajun Facs Corp ,Lafayette Pub Trust Fincg Auth

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: This Credit Rating Report will be emailed to you.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.